HOME-GROWN biotech companies would rather look for opportunities further ashore than list on the Singapore Exchange (SGX). Although the city-state has a growing biotech ecosystem, the local bourse has not been able to benefit much from it.
Industry players who spoke to
To find out more
CALL +65 6388 3838 EMAIL email@example.com